Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02608125
Title A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Principia Biopharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Cener San Francisco California 94115 United States Details
Johns Hopkins Medicine Baltimore Maryland 21205 United States Details
Wake Forest University Health Sciences Medical Center Winston-Salem North Carolina 27157 United States Details
Tennessee Oncology, Sarah Canon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Barcelona 08035 Spain Details
Hospital General Universitario de Elche Elche 03203 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
START Madrid-FJD Fundacion Jiminez Diaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
START Madrid-CIOCC, Centro Integral Oncológico Clara Campal Madrid 28050 Spain Details
Hospital Virgen del Rocio Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field